Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
Weiva Sieh(The University of Texas MD Anderson Cancer Center), Marcus Q. Bernardini(University Health Network), Jennifer Alsop(Manchester Academic Health Science Centre), Brooke L. Fridley(Children's Mercy Hospital), Julie M. Cunningham(Cancer Research UK), Allan Jensen(Danish Cancer Society), Kunle Odunsi(University of Chicago), Mark E. Sherman(Mayo Clinic in Florida), Lynne R. Wilkens(University of Hawaiʻi at Mānoa), Claus Høgdall(Copenhagen University Hospital), Michael E. Carney(The University of Texas MD Anderson Cancer Center), Robert A. Vierkant(Mayo Clinic), Anna DeFazio(The University of Sydney), David D.L. Bowtell(The University of Melbourne), Jason Madore(QIMR Berghofer Medical Research Institute), Estrid Høgdall(University of Copenhagen), C. Blake Gilks(Vancouver General Hospital), Susanne K. Kjær(Copenhagen University Hospital), Marc T. Goodman(Cedars-Sinai Medical Center), Wiam Bshara(National Institutes of Health), Joshy George(Jackson Laboratory), James D. Brenton(Cambridge University Hospitals NHS Foundation Trust), Suha Deen(Nottingham University Hospitals NHS Trust), Shashikant Lele(Memorial Sloan Kettering Cancer Center), Sián Fereday(Peter MacCallum Cancer Centre), Laura Galletta(Peter MacCallum Cancer Centre), Barry P. Rosen(Florida International University), Andre Kim, Carl Morrison(Roswell Park Comprehensive Cancer Center), Nicolas Wentzensen(National Cancer Institute), Kimberly R. Kalli(Mayo Clinic), Marie Mack(University of Cambridge), Valerie McGuire(Cargill (Netherlands)), Louise A. Brinton(National Cancer Institute), Blaise Clarke(Princess Margaret Cancer Centre), Montserrat García‐Closas(Institute of Cancer Research), Usha Menon(University of South Florida), Hannah Yang(Cancer Prevention Institute of California), Martin Köbel(University of Calgary), Teri A. Longacre(Palo Alto University), Galina Lurie(Cancer Prevention Institute of California), Rayna K. Matsuno(Cancer Prevention Institute of California), Kirsten B. Moysich(Roswell Park Comprehensive Cancer Center), Gary L. Keeney(Mayo Clinic in Arizona), Joseph H. Rothstein(University of Washington Medical Center), Pamela J. Thompson(Cancer Prevention Institute of California), Lara Sucheston(Roswell Park Comprehensive Cancer Center), Jolanta Lissowska, Kristy Driver(University of Cambridge), Mercedes Jimenez‐Liñan(University of Kansas)
Cited by 434
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
|JNCI Journal of the National Cancer Institute|1995|3.4k
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k